BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 27659702)

  • 1. MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation.
    Vroomen LGPH; Scheffer HJ; Melenhorst MCAM; de Jong MC; van den Bergh JE; van Kuijk C; van Delft F; Kazemier G; Meijerink MR
    Eur Radiol; 2017 Jun; 27(6):2521-2531. PubMed ID: 27659702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience.
    Belfiore MP; Ronza FM; Romano F; Ianniello GP; De Lucia G; Gallo C; Marsicano C; Di Gennaro TL; Belfiore G
    Int J Surg; 2015 Sep; 21 Suppl 1():S34-9. PubMed ID: 26118600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
    Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
    Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal Study.
    Barabasch A; Distelmaier M; Heil P; Krämer NA; Kuhl CK; Bruners P
    Invest Radiol; 2017 Jan; 52(1):23-29. PubMed ID: 27379698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.
    Scheck J; Bruners P; Schindler D; Kuhl C; Isfort P
    Korean J Radiol; 2018; 19(4):560-567. PubMed ID: 29962862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
    Marsanic P; Mellano A; Sottile A; De Simone M
    Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
    Martin RC; McFarland K; Ellis S; Velanovich V
    J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible electroporation of pancreatic adenocarcinoma: a primer for the radiologist.
    Rashid MF; Hecht EM; Steinman JA; Kluger MD
    Abdom Radiol (NY); 2018 Feb; 43(2):457-466. PubMed ID: 29051982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia.
    Yang PC; Huang KW; Pua U; Kim MD; Li SP; Li XY; Liang PC
    Eur J Surg Oncol; 2020 May; 46(5):811-817. PubMed ID: 31839436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
    Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
    Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
    van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
    Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.
    Sugimoto K; Moriyasu F; Saito K; Kobayashi Y; Itoi T
    J Med Ultrason (2001); 2017 Jul; 44(3):247-254. PubMed ID: 27933441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI and CT in the follow-up after irreversible electroporation of small renal masses.
    Buijs M; de Bruin DM; Wagstaff PG; J Zondervan P; Scheltema MJ; W Engelbrecht M; P Laguna M; van Lienden KP
    Diagn Interv Radiol; 2021 Sep; 27(5):654-663. PubMed ID: 34559050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-enhanced Pattern on Contrast-Enhanced Ultrasound in the Local Efficacy Assessment of Irreversible Electroporation Ablation of Pancreatic Adenocarcinoma.
    Lin M; Xie X; Xu M; Feng S; Tian W; Zhuang B; Su L; Ye J; Lin J; Liang P; Yu J; Kuang M
    Ultrasound Med Biol; 2018 Sep; 44(9):1986-1995. PubMed ID: 30055820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
    van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
    J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones.
    Guo Y; Zhang Y; Nijm GM; Sahakian AV; Yang GY; Omary RA; Larson AC
    Radiology; 2011 Feb; 258(2):461-8. PubMed ID: 21131581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.
    Zhang Y; White SB; Nicolai JR; Zhang Z; West DL; Kim DH; Goodwin AL; Miller FH; Omary RA; Larson AC
    Radiology; 2014 Jun; 271(3):721-9. PubMed ID: 24555632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.